Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Klassen Preston, Chief Executive Officer. Director active across 3 companies, notably Metacrine, Inc.. In total, 12 disclosures have been recorded. Breakdown: 2 buys · 3 sells. Total volume traded: €348k. Activity tracked since 20 May 2021. The latest transaction was filed on 3 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Klassen Preston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Klassen Preston is Directeur Général. He has 12 filings in total, and in the recent sample covered, the reported transactions run from 2016-02-04 to 2025-06-27, with EUR 145292 of purchases and EUR 203032 of sales. His recent filings concern Metacrine, Inc., Regulus Therapeutics Inc. and Orexigen Therapeutics, Inc., and the most frequent transaction nature is Attribution.